Intel just pulled off one of the most spectacular rallies in semiconductor history, with shares rocketing 490% over the past year. But the chip giant’s stunning market performance might be writing checks its actual business can’t yet cash. Wall Street’s enthusiasm is running white-hot on promises of a manufacturing renaissance and AI chip ambitions, even as the company’s operational turnaround remains very much a work in progress.

Intel is experiencing something rare in Silicon Valley: a second act so dramatic it’s making even the most skeptical analysts do a double-take. The stock’s 490% climb over the past year represents one of the most aggressive rebounds in semiconductor history, driven by a potent cocktail of new leadership, manufacturing promises, and Wall Street’s appetite for a good redemption story.

But here’s the uncomfortable truth lurking beneath the celebration: Intel’s actual business performance hasn’t caught up to its market valuation. Not even close. The company that spent years ceding ground to Nvidia in AI chips, losing Apple as a customer, and stumbling through manufacturing delays is now valued like it’s already completed a turnaround that’s barely begun.

The rally accelerated dramatically after Lip-bu Tan took the CEO reins, bringing decades of semiconductor industry credibility and a reputation for operational excellence. Investors immediately started pricing in success, betting that Tan could reverse the damage from Intel’s lost decade. According to market analysts tracking the surge, much of the momentum stems from speculation around potential foundry contracts, particularly rumors of Apple bringing some chip production back to American soil through Intel’s manufacturing facilities.

That Apple connection is doing serious heavy lifting in Intel’s narrative. The idea that Intel could win back its former customer, not as a chip designer but as a manufacturer, has Wall Street dreaming of a business model transformation. Intel Foundry Services, the company’s bet on becoming a contract chipmaker like TSMC, remains largely unproven at the scale needed to justify current valuations. The division has announced partnerships and secured some government funding through the CHIPS Act, but actual production volumes and profit margins remain question marks.

The timing of Intel’s rally also coincides with broader market rotation away from the AI darlings that dominated 2024 and early 2025. As Nvidia and other AI infrastructure plays cooled off, investors started hunting for recovery stories in traditional semiconductor names. Intel became the poster child for this rotation, with funds piling in based on the premise that the company was “too big to fail” and “due for a comeback.”

But the fundamentals tell a more complicated story. Intel’s latest product roadmap shows progress, with new chip architectures finally competitive again after years of delays. The company’s AI accelerator efforts are gaining some traction in enterprise markets. Manufacturing technology is improving, with Intel claiming it’s back on track to match or exceed rivals’ process node capabilities. Yet none of this has translated into the kind of market share gains or profit margins that would typically justify a near-500% stock appreciation.

Competitive pressure remains intense. Nvidia continues to dominate AI training chips, AMD keeps taking server market share, and TSMC’s manufacturing lead in cutting-edge processes hasn’t disappeared overnight. Intel’s comeback requires not just executing on its own roadmap but doing so while rivals stand still, which history suggests is unlikely.

The semiconductor industry has seen speculative runs before. Investors bet big on turnaround stories, particularly when they involve iconic American tech companies fighting back against Asian manufacturing dominance. Intel’s narrative hits all those emotional buttons, wrapped in themes of reshoring, national security, and technological sovereignty. The CHIPS Act funding adds governmental validation to the comeback thesis, making it easier for institutional investors to justify positions.

What’s particularly striking about Intel’s rally is how front-loaded the optimism appears. Typically, turnaround stocks rally as they hit milestones and prove skeptics wrong. Intel’s gaining as if it’s already succeeded, pricing in best-case scenarios across multiple business lines simultaneously. The foundry business, the AI chip portfolio, the traditional CPU recovery—Wall Street seems to be assuming Intel wins on all fronts.

Some veteran chip analysts are raising yellow flags. The valuation multiples Intel now commands assume profitability levels the company hasn’t achieved in years and market positions it doesn’t currently hold. If execution stumbles, if Apple goes elsewhere for manufacturing, if the foundry business takes longer to scale than projected, the stock has a long way to fall.

Yet the rally continues, fed by momentum, short covering, and genuine belief that American semiconductor manufacturing matters enough that Intel will find a way. The company’s challenges are well-documented: cultural issues, manufacturing complexities, fierce competition, and the sheer difficulty of competing across multiple chip markets simultaneously. Turning around an organization of Intel’s size and complexity typically takes years, not quarters.

The market’s current pricing suggests investors believe Lip-bu Tan is pulling off something extraordinary. Maybe he is. The ingredients for a comeback exist: government support, improving technology, enterprise customer relationships, and massive scale. But ingredients aren’t the same as the finished dish, and Intel’s cooking time might be longer than Wall Street’s expecting.

Intel’s 490% stock surge is either the early recognition of a historic turnaround or one of the most aggressive instances of Wall Street getting ahead of itself. The truth probably lies somewhere in between. The company has genuine momentum under new leadership, real technological progress, and powerful tailwinds from reshoring trends and government support. But the execution risk remains enormous, the competitive landscape brutal, and the timeline uncertain. Investors betting on Intel at current levels aren’t just buying the comeback—they’re buying the perfect comeback, with flawless execution across multiple fronts simultaneously. That’s a high bar for any company to clear, let alone one trying to reverse a decade of decline. The next 12 months will reveal whether Wall Street’s optimism was prescient or premature.